Arch Venture Fund V LP

Arch Venture Fund V LP has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Impinj Inc, Trubion Pharmaceuticals, Inc and NeurogesX Inc. In total, 20 filings cover trades dated from 17 October 2006 to 26 July 2016.

In open-market terms, that means 3 purchases worth €4.3M on one side and 3 sales on the other. The amount is not disclosed for 3 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants.

The median purchase comes to €1.8M.

The newest entry dates from 30 August 2016: a share grant of €272k, in Impinj Inc. The clock since the last published purchase (25 July 2011) now reads 5,569 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.